OpenBiome announces members of its Clinical Advisory Board
The thought leaders on fecal microbiota transplantation (FMT) lend medical guidance to OpenBiome’s production and research activities
Medford, MA – OpenBiome welcomed the new members of its Clinical Advisory Board, an independent panel of medical and scientific experts who provide clinical advice to drive FMT best practices. The Board provides unbiased input that adds to the decision-making capacity of OpenBiome staff as the organization works to improve the standard of care for FMT.
The members of the Clinical Advisory Board are academic leaders and distinguished clinicians dedicated advancing the research and practice of FMT. They are:
Dr. Ciaran Kelly
Dr. Kelly is a Professor of Medicine at Harvard Medical School and Chief of the Herrman L. Blumgart Internal Medicine Firm, Director of Gastroenterology Training and Medical Director of the Celiac Center at Beth Israel Deaconess Medical Center, Boston, Massachusetts. He is an American Gastroenterology Association Fellow and a Fellow of the College of Gastroenterology. He has served as a committee member of the National Institutes of Health, Center for Scientific Review and leads NIH-funded research programs on C. difficile colitis and inflammatory bowel disease. He heads clinical, research and educational programs in celiac disease as Medical Director of the Celiac Center at BIDMC. Dr. Kelly is author on more than 100 clinical and basic research book chapters, invited reviews, and peer-reviewed publications appearing in such journals as Infection & Immunity, American Journal of Physiology, Gastroenterology, Journal of Biological Chemistry, Journal of Clinical Investigation, The Lancet and New England Journal of Medicine.
Dr. Colleen Kelly
Dr. Kelly is a gastroenterologist in the Center for Women’s Gastrointestinal Medicine at the Women’s Medicine Collaborative. She is an assistant professor of medicine at The Warren Alpert Medical School of Brown University and a faculty member in the fellowship pathway in women’s gastrointestinal diseases at Alpert Medical School. She is nationally recognized in the field of gut flora and its implication in recurrent C. difficile infection. The focus of her research and clinical practice is fecal microbiota transplant (FMT) and she has assisted many physicians and institutions in developing FMT protocols. Kelly has authored a number of papers and abstracts on the subject and was a member of a working group that drafted a best-practices article for treating C. difficile infection with FMT, published in 2011. She is a principal investigator for the first US clinical trial of FMT to treat relapsing C. difficile infection.
Dr. Daniel Murphy
Dr. Murphy is a gastroenterologist and internal medicine specialist. He served as president of the medical Staff of Forsyth Medical Center and is a member of several medical professional committees and societies. Dr. Murphy also is a consultant as Investigator to Piedmont Medical Research in Clinical Trials involving areas of constipation, duodenal ulcer, dyspepsia, gastric ulcer, GERD, heartburn, irritable bowel syndrome, and ulcerative colitis.
Dr. Kanchana Amaratunga
Dr. Amaratunga is an Infectious Diseases and Internal Medicine physician. She completed her training at McMaster University, Canada and is Royal College certified in each of these disciplines. She subsequently went on to complete a Master of Public Health at the Harvard School of Public Health with a focus on Quantitative Methods. She currently works as a Medical Advisor for the Centre for Communicable Diseases and Infection Control at the Public Health Agency of Canada and has a focus on hospital acquired infections.
Dr. Michael B. Edmond
Dr. Edmond is the Chief Quality Officer for the University of Iowa Hospitals and Clinics. Previously, he was the Richard P. Wenzel Professor of Internal Medicine in the Division of Infectious Diseases at Virginia Commonwealth University and held a faculty appointment in the Department of Epidemiology and Community Health and served as the Hospital Epidemiologist for the VCU Health System. Dr. Edmond’s areas of research focus on the epidemiology of healthcare-associated infections and the public policy implications of infection control. He has published 350 papers, abstracts and book chapters, and co-writes a blog entitled Controversies in Hospital Infection Prevention. Over the past few years, Dr. Edmond has been named to Richmond Magazine’s Top Doctors, America’s Top Doctors, US News and World Report’s Top Doctors, Our Health Richmond Magazine’s Best Bedside Manner Award, and Health Leaders Magazine’s 20 People Who Make Healthcare Better.
Dr. Neil Stollman
Dr. Stollman is a gastroenterologist and Director of the East Bay Center for Digestive Health Research, Chairman of the Department of Medicine at Alta Bates Summit Medical Center in Oakland, and teaches frequently at medical schools in the region. Previously, he held a faculty position at the University of Miami/Jackson Memorial Hospital and served as Chief of Gastroenterology at the Miami VA Medical Center, and Chief of Gastroenterology at San Francisco General Hospital, and Associate Clinical Professor of Medicine in the Division of Gastroenterology at the University of California San Francisco. Dr. Stollman has authored many book chapters and peer-reviewed articles on diverticular disease, reflux disease, H. pylori, gastrointestinal bleeding, dysmotility, and Barrett’s esophagus.
Dr. Paul Beck
Dr. Beck is a Professor in the Department of Medicine, Division of Gastroenterology at the University of Calgary. He is Director of the Leaders in Medicine MD-PhD/MD-MSc program at the University of Calgary’s Cumming School of Medicine. Since 1999 Dr. Beck has been on staff as a clinician scientist at the University of Calgary/Foothills Hospital where he is director of research, Gastroenterology Division and GI Fellows Program. He has published over 130 paper and in the past 5 years he has published over 50 papers in top levels journals including Science, Nature Medicine, Gastroenterology, Blood, PNAS and others. He is a recipient of the International Research Mentor Award, from the American Gastroenterology Association Institute Council Immunology, Microbiology and Inflammatory Bowel Disease Section, the Citation Classic Award, University of Calgary for a single paper being cited over 1000 times, and the 2013-2014 Canadian Association of Gastroenterology Visiting Professor Research Lectureship.
Dr. Paul Moayyedi
Dr. Moayyedi is a Professor of Medicine, and the Richard Hunt-Astra Zeneca Chair in Gastroenterology at McMaster University. He became Director of the Division of Gastroenterology at McMaster in 2006. He is the joint Editor-in-Chief of the Upper Gastrointestinal and Pancreatic Diseases Cochrane Group and the joint Editor-in-Chief of the American Journal of Gastroenterology. He has been involved in the development of several national and international guidelines including the American Gastroenterology Association and the England and Wales National Institute of Clinical Excellence dyspepsia and the American College of Gastroenterology IBS guidelines. Dr. Moayyedi has over 270 peer-reviewed publications. His work has been cited over 7,700 times with 1194 citations in 2013, and was awarded the 2014-2015 Canadian Association of Gastroenterology Visiting Professor Research Lectureship.
Dr. Richard H. Hunt
Dr. Hunt is a Professor of Medicine Emeritus at McMaster University. He was the first Director of the Intestinal Disease Research Unit, and of the Division of Gastroenterology. Dr. Hunt is a Fellow of the Royal College of Physicians of London, Edinburgh, and Canada, and a Master of the American College of Gastroenterology. He has been recognized with many honors for his work in Gastroenterology, where his special interests focus on the acid related disorders and the clinical pharmacology of treatment of gastrointestinal disease. He is also widely recognized for an extensive interest in colorectal disease, colonoscopy, and therapeutic endoscopy. Dr. Hunt has served as President of the Canadian Association of Gastroenterology and of the Canadian Helicobacter Study Group, and Vice President of the Canadian Digestive Health Foundation. Dr. Hunt has been Associate Editor of the Esophagus, Stomach and Duodenum, sections of Gastroenterology, and a member of the Editorial Boards of 20 scientific journals. He has published over 600 papers and abstracts including authoritative papers on clinical pharmacology, peptic ulcer disease, gastroesophageal reflux disease, Helicobacter pylori infection, colonic disease, and colonoscopy. He is the author or editor of 11 books and 63 chapters, and has produced 20 TV video films on peptic ulcer disease, reflux esophagitis, and colonoscopy.
Dr. Timothy O’Shea
Dr. O’Shea is an Assistant Professor in the Department of Medicine, Division of Infectious Diseases at McMaster University, Canada. He trained in internal medicine, infectious diseases and medical microbiology at McMaster, and is Royal College certified in each of these disciplines. He has served as the International Electives coordinator for the Michael Degroote School of Medicine at McMaster University, and as an internal medicine consultant for the Shelter Health Network in Hamilton. He holds a Masters of Public Health degree from the Harvard School of Public University.
OpenBiome is a nonprofit stool bank dedicated to expanding safe access to fecal microbiota transplantation (FMT) therapies. Founded by a team of microbiologists, public health advocates, and concerned citizens, OpenBiome aims to significantly reduce the practical barriers for clinicians providing FMTs, while connecting scientists across studies and disciplines.